IHE stock forecast, quote, news & analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI).

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

The average market capitalization across the iShares US Pharmaceuticals ETF ETF is 55.91B. The market cap for tickers in the group ranges from 326.29M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is AMLX at 326.29M.

The average weekly price growth across all stocks in the iShares US Pharmaceuticals ETF ETF was -4%. For the same ETF, the average monthly price growth was -7%, and the average quarterly price growth was 2%. RVNC experienced the highest price growth at 13%, while AMLX experienced the biggest fall at -29%.

The average weekly volume growth across all stocks in the iShares US Pharmaceuticals ETF ETF was 54%. For the same stocks of the ETF, the average monthly volume growth was 182% and the average quarterly volume growth was 136%